Researchers have reported on a new utility of the PET tracer florbetapir. They found that the tracer can distinguish frontotemporal dementia (FTD) from Alzheimer’s disease and the cognitively normal elderly.  This ability removes the need for a separate scan to identify FTD, which can cause significant stress in such patients. {read more here}